Lpl Financial LLC Syros Pharmaceuticals, Inc. Transaction History

Lpl Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.69 - $1.21 $16,560 - $29,040	-24,000 Reduced 19.81%	97,135 $94,000
Q1 2022 May 16, 2022	BUY	$1.02 - $3.8 $52,096 - $194,085	51,075 Added 72.9%	121,135 $144,000
Q4 2021 Feb 14, 2022	BUY	$3.26 - $4.66 $74,800 - $106,923	22,945 Added 48.7%	70,060 $228,000
Q3 2021 Nov 15, 2021	BUY	$4.08 - $5.66 $36,822 - $51,081	9,025 Added 23.69%	47,115 $211,000
Q2 2021 Aug 13, 2021	BUY	$5.01 - $7.48 $93,997 - $140,339	18,762 Added 97.07%	38,090 $208,000
Q1 2021 May 14, 2021	BUY	$7.19 - $14.95 $38,164 - $79,354	5,308 Added 37.86%	19,328 $145,000
Q4 2020 Feb 12, 2021	BUY	$6.66 - $14.66 $93,373 - $205,533	14,020 New	14,020 $152,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.